DMPK
Designing preclinical DMPK and PK/PD strategies that connect exposure, bioanalysis, and translational decision-making across therapeutic programs.
Life sciences advisory
Scientific clarity for complex therapeutic programs.
Zubair Bio Consulting works with pharmaceutical and biotech companies where biology, translational strategy, and business judgment need to meet — with particular depth in DMPK and biomarkers.
Focused advisory
Making complex opportunities easier to evaluate, communicate, and advance.
Expertise
Technical depth with a translational point of view.
Biomarkers
Building translational biomarker strategies, patient-stratification hypotheses, assay priorities, and evidence plans that help programs move forward with confidence.
Advanced Mass Spectrometry
Applying LC-MS/MS and high-resolution mass spectrometry to bioanalysis, biomarker measurement, method development, and translational study support.
Selected projects
Where the science becomes a decision.
Representative project areas spanning preclinical development, translational planning, and bioanalytical strategy.
Preclinical DMPK & PK/PD Strategy
Study design for exposure-response questions, including bioanalysis, pharmacokinetics, pharmacodynamics, and translational modeling.
DMPKPK/PDBioanalysis
Translational Biomarker Programs
From discovery through clinical planning: define the biomarker question, align assay priorities, and build an evidence plan around the therapeutic hypothesis.
BiomarkersTranslationPatient stratification
Mass Spectrometry & Bioanalytical Support
Technical and strategic guidance for LC-MS/MS and high-resolution workflows that turn complex measurements into usable program insight.
LC-MS/MSHRMSMethod development
About
A practical partner for high-stakes science.
Zubair Life Sciences Advisory works with pharmaceutical and biotech companies on questions where biology, translational strategy, and business judgment need to meet.
The focus is on making complex therapeutic and biomarker opportunities easier to evaluate, communicate, and advance. Engagements are grounded in scientific rigor, clear communication, and practical next steps.
From preclinical PK/PD study design and DMPK strategy to biomarker discovery and advanced mass spectrometry, Zubair brings focused expertise to the decisions that shape a program's trajectory.
Contact
Have a program question to work through?
If you are evaluating a DMPK, biomarker, or translational challenge, let's start with the scientific question and identify the clearest path forward.
FaizanZubair2@gmail.com